Meta-analysis of randomized clinical trials of adjuvant chemotherapy for resected biliary tract cancers
- 26 April 2020
- journal article
- review article
- Published by Elsevier BV in HPB
- Vol. 22 (7), 939-949
- https://doi.org/10.1016/j.hpb.2020.02.001
Abstract
No abstract availableFunding Information
- Fundamental Research Funds for the Central Universities
- West China Hospital, Sichuan University
- Department of Science and Technology of Sichuan Province
- Sichuan University
This publication has 45 references indexed in Scilit:
- Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factorsCancer Cell International, 2013
- Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary AdenocarcinomaJAMA, 2012
- Neither Neoadjuvant nor Adjuvant Therapy Increases Survival After Biliary Tract Cancer Resection with Wide Negative MarginsJournal of Gastrointestinal Surgery, 2012
- Intrahepatic CholangiocarcinomaAnnals of Surgery, 2010
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerNew England Journal of Medicine, 2010
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma?Cancer, 2002
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996